Mitsubishi Tanabe Pharma has undergone a rebrand. Following a 510 billion Japanese yen ($3.3 billion) takeover by Bain Capital, the 350-year-old company has dropped Mitsubishi from its name and those ...

Microsize, a U.S.-based CDMO that specializes in particle size reduction and control technologies, has linked with Swiss equipment provider Schedio Group ...

In the wake of the memo, several vaccine experts responded that the CBER director's claim about the deaths requires more ...

Following the deal’s Nov. 26 close, Omnicom on Monday outlined the structure of the newly combined company, including leaders ...

The Trump administration has lined up another country-specific trade agreement, this time with the U.K., which confers Washington’s biggest break on pharmaceutical import tariffs yet. | The Trump ...

In the early November announcement of its agreement with the government, Lilly pledged to reduce the self-pay price of ...

In this episode of Health Matters, GCI Health’s Ryan Kuresman and Health@WPP’s Wendy Lund explore the fast-shifting landscape ...

The United States has revealed price reductions for the second round of | The U.S. has revealed price reductions for the ...

Novo Nordisk is using its ticket for an extra-speedy regulatory review granted through the FDA’s Commissioner’s National ...

A new FDA approval for a first-in-class drug has vaulted Otsuka into immunoglobulin A nephropathy (IgAN), an increasingly competitive kidney disease field targeted by multiple biopharma companies.

More than 30 agents conducted a surprise raid of Sanofi’s headquarters in Paris on Tuesday morning as part of a tax fraud ...